Super Bowl XLIX: Patriots Coverage  |  Seahawks Coverage  |  Share Your Photos |  Buy Gear

BLIZZARD WARNING: ClosingsRadar | Current Conditions | Blog | Traffic | Share Photos | Weather App

Alnylam Pharmaceuticals

(Photo credit MIGUEL MEDINA/AFP/Getty Images)

Genzyme Jumps Into Rapidly Growing Business Of Genetic Medicines

Genzyme is spending $700 million dollars to buy a chunk of Alnylam Pharmaceuticals of Cambridge — a much smaller company that been moving rapidly toward commercializing treatments for rare genetic diseases.

01/13/2014

Follow

Get every new post delivered to your Inbox.

Join 3,428 other followers